Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Early Stage, Growth
Geographical Focus
United States, Hong Kong, Japan, Australia, Singapore, China, India, Indonesia, South Korea, Pakistan, Bangladesh, Vietnam, Malaysia, New Zealand, Philippines, Thailand, Taiwan, Sri Lanka, Macau
Industries Focus
- Medical Devices
- Biopharmaceuticals
- Digital Healthcare Services
Investor Details
TransPacific Venture Capital Partners is a venture capital firm investing in early-stage companies with a focus on Asia and the U.S. The firm specializes in sectors such as biopharmaceuticals, medical devices, and digital healthcare services, aiming to support innovations that enhance human health and productivity.
Their investment strategy targets companies in late stages of clinical development, emphasizing novel therapeutics for major diseases like Alzheimer's. They also pursue investments in medical technologies and digital health, particularly those leveraging artificial intelligence to transform healthcare delivery.
The firm's team comprises healthcare executives and practitioners with extensive experience across the biopharmaceutical and healthcare industries in the Pacific Rim. They collaborate closely with senior management in their portfolio companies, driving business and product development strategies to address unmet medical needs and advance medical treatments across various therapeutic areas.
Requirements
- Companies in late stages of clinical development
- Focus on biopharmaceuticals, medical devices, and digital healthcare services
- Innovations that enhance human health and productivity
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Mentioned In
-
$9.95
-
$24.95
-
$19.95
-
$9.95
-
$49.95
-
$9.95
-
$14.95
-
$39.95
-
$299.00
Claim this Investor
Are you an official representative of TransPacific Venture Capital Partners?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim